October 2004

Volume 4 Issue 10

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
When did the HeartStart Home Defibrillator first become available on the market? The HeartStart Home Defibrillator received FDA clearance in November 2002. This was for prescription-use only. It was the first of a new generation of defibrillators spe…
When was the EP lab started at your institution? Dr. Jeremy Ruskin is the founder and director of the MGH Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory, the first subspecialty service dedicated to the care of patients with card…
Hypertrophic cardiomyopathy (HCM) is one of the oldest known causes of sudden death. It was first described in 1958. It has been called HOCM (hypertrophic obstructive cardiomyopathy) and also IHSS (idiopathic hypertrophic subaortic stenosis), despite…
From 2004, Vol. 4, No. 8: At the University of Florida, they are a referral center for ablation of complex arrhythmias, lead extractions, and biventricular pacing. They perform almost equal amounts of ablations and device implants. From 2004, Vol.…
Femoral Sheaths Our EP nurses are going to start putting the femoral venous sheaths in for the electrophysiology cases. There does not seem to be any other centre in the United Kingdom that is doing this; could anyone help with information/protocols/…
What are the current pharmacological options available for AF patients? The current pharmacological options available to treat patients with AF are often directed at antithrombotic therapy and efforts to optimally control the ventricular response. Wi…
I have the difficult task to talk about t-wave alternans on a cellular level to a crew of clinical electrophysiologists. I will try to make it simple.